Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis
Published 2021 View Full Article
- Home
- Publications
- Publication Search
- Publication Details
Title
Genome-wide gene expression tuning reveals diverse vulnerabilities of M. tuberculosis
Authors
Keywords
Mycobacterium tuberculosis, Mycobacterium smegmatis, Essential genes, Vulnerability, Bayes Theorem, Mass Spectrometry, CRISPR-Cas Systems, Drug Development
Journal
CELL
Volume 184, Issue 17, Pages 4579-4592.e24
Publisher
Elsevier BV
Online
2021-07-22
DOI
10.1016/j.cell.2021.06.033
References
Ask authors/readers for more resources
Related references
Note: Only part of the references are listed.- Titrating gene expression using libraries of systematically attenuated CRISPR guide RNAs
- (2020) Marco Jost et al. NATURE BIOTECHNOLOGY
- SciPy 1.0: fundamental algorithms for scientific computing in Python
- (2020) Pauli Virtanen et al. NATURE METHODS
- New 2-Ethylthio-4-methylaminoquinazoline derivatives inhibiting two subunits of cytochrome bc1 in Mycobacterium tuberculosis
- (2020) Andréanne Lupien et al. PLoS Pathogens
- GenomegaMap: within-species genome-wide dN/dS estimation from over 10,000 genomes
- (2020) Daniel J Wilson et al. MOLECULAR BIOLOGY AND EVOLUTION
- Redefining fundamental concepts of transcription initiation in bacteria
- (2020) Citlalli Mejía-Almonte et al. NATURE REVIEWS GENETICS
- Mismatch-CRISPRi Reveals the Co-varying Expression-Fitness Relationships of Essential Genes in Escherichia coli and Bacillus subtilis
- (2020) John S. Hawkins et al. Cell Systems
- A simplified strategy for titrating gene expression reveals new relationships between genotype, environment, and bacterial growth
- (2020) Andrew D Mathis et al. NUCLEIC ACIDS RESEARCH
- Multi-omics Analysis of CRISPRi-Knockdowns Identifies Mechanisms that Buffer Decreases of Enzymes in E. coli Metabolism
- (2020) Stefano Donati et al. Cell Systems
- Prioritization of cancer therapeutic targets using CRISPR–Cas9 screens
- (2019) Fiona M. Behan et al. NATURE
- Large-scale chemical–genetics yields new M. tuberculosis inhibitor classes
- (2019) Eachan O. Johnson et al. NATURE
- Identification of new components of the RipC-FtsEX cell separation pathway of Corynebacterineae
- (2019) Hoong Chuin Lim et al. PLoS Genetics
- Tuberculosis drug discovery in the CRISPR era
- (2019) Jeremy Rock PLoS Pathogens
- Genome-Scale Identification of Essential Metabolic Processes for Targeting the Plasmodium Liver Stage
- (2019) Rebecca R. Stanway et al. CELL
- Genome-wide Phenotypic Profiling Identifies and Categorizes Genes Required for Mycobacterial Low Iron Fitness
- (2019) Marte S. Dragset et al. Scientific Reports
- Antimalarial activity of single-dose DSM265, a novel plasmodium dihydroorotate dehydrogenase inhibitor, in patients with uncomplicated Plasmodium falciparum or Plasmodium vivax malaria infection: a proof-of-concept, open-label, phase 2a study
- (2018) Alejandro Llanos-Cuentas et al. LANCET INFECTIOUS DISEASES
- Tuning dCas9's ability to block transcription enables robust, noiseless knockdown of bacterial genes
- (2018) Antoine Vigouroux et al. Molecular Systems Biology
- A CRISPRi screen in E. coli reveals sequence-specific toxicity of dCas9
- (2018) Lun Cui et al. Nature Communications
- TnSeq of Mycobacterium tuberculosis clinical isolates reveals strain-specific antibiotic liabilities
- (2018) Allison F. Carey et al. PLoS Pathogens
- Targeting the Proteostasis Network for Mycobacterial Drug Discovery
- (2018) Tania J. Lupoli et al. ACS Infectious Diseases
- Genome-wide CRISPR-dCas9 screens in E. coli identify essential genes and phage host factors
- (2018) François Rousset et al. PLoS Genetics
- High-throughput biochemical profiling reveals sequence determinants of dCas9 off-target binding and unbinding
- (2017) Evan A. Boyle et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- Comprehensive Essentiality Analysis of the Mycobacterium tuberculosis Genome via Saturating Transposon Mutagenesis
- (2017) Michael A. DeJesus et al. mBio
- Crosstalk between transcription and metabolism: how much enzyme is enough for a cell?
- (2017) Stefano Donati et al. Wiley Interdisciplinary Reviews-Systems Biology and Medicine
- Construction and Analysis of Two Genome-Scale Deletion Libraries for Bacillus subtilis
- (2017) Byoung-Mo Koo et al. Cell Systems
- Programmable transcriptional repression in mycobacteria using an orthogonal CRISPR interference platform
- (2017) Jeremy M. Rock et al. Nature Microbiology
- Imidazo[1,2-a]Pyridine-3-Carboxamides Are Active Antimicrobial Agents against Mycobacterium avium InfectionIn Vivo
- (2016) Garrett C. Moraski et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Massively Parallel Interrogation of the Effects of Gene Expression Levels on Fitness
- (2016) Leeat Keren et al. CELL
- Investigating essential gene function inMycobacterium tuberculosisusing an efficient CRISPR interference system
- (2016) Atul K. Singh et al. NUCLEIC ACIDS RESEARCH
- Validation of CoaBC as a Bactericidal Target in the Coenzyme A Pathway of Mycobacterium tuberculosis
- (2016) Joanna C. Evans et al. ACS Infectious Diseases
- Absolute Proteome Composition and Dynamics during Dormancy and Resuscitation of Mycobacterium tuberculosis
- (2015) Olga T. Schubert et al. Cell Host & Microbe
- Gene silencing by CRISPR interference in mycobacteria
- (2015) Eira Choudhary et al. Nature Communications
- Structure, Activity, and Inhibition of the Carboxyltransferase β-Subunit of Acetyl Coenzyme A Carboxylase (AccD6) from Mycobacterium tuberculosis
- (2014) Manchi C. M. Reddy et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- A Novel Inhibitor of Gyrase B Is a Potent Drug Candidate for Treatment of Tuberculosis and Nontuberculosis Mycobacterial Infections
- (2014) Christopher P. Locher et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Respiratory Flexibility in Response to Inhibition of CytochromecOxidase in Mycobacterium tuberculosis
- (2014) Kriti Arora et al. ANTIMICROBIAL AGENTS AND CHEMOTHERAPY
- Genome-Scale CRISPR-Mediated Control of Gene Repression and Activation
- (2014) Luke A. Gilbert et al. CELL
- Metabolic and Bactericidal Effects of Targeted Suppression of NadD and NadE Enzymes in Mycobacteria
- (2014) I. A. Rodionova et al. mBio
- Repurposing CRISPR as an RNA-Guided Platform for Sequence-Specific Control of Gene Expression
- (2013) Lei S. Qi et al. CELL
- Discovery of Q203, a potent clinical candidate for the treatment of tuberculosis
- (2013) Kevin Pethe et al. NATURE MEDICINE
- The Subread aligner: fast, accurate and scalable read mapping by seed-and-vote
- (2013) Yang Liao et al. NUCLEIC ACIDS RESEARCH
- Global Assessment of Genomic Regions Required for Growth in Mycobacterium tuberculosis
- (2012) Yanjia J. Zhang et al. PLoS Pathogens
- Depletion of antibiotic targets has widely varying effects on growth
- (2011) J.-R. Wei et al. PROCEEDINGS OF THE NATIONAL ACADEMY OF SCIENCES OF THE UNITED STATES OF AMERICA
- High-Resolution Phenotypic Profiling Defines Genes Essential for Mycobacterial Growth and Cholesterol Catabolism
- (2011) Jennifer E. Griffin et al. PLoS Pathogens
- SnapShot: The Replisome
- (2010) Nina Y. Yao et al. CELL
- Human T cell epitopes of Mycobacterium tuberculosis are evolutionarily hyperconserved
- (2010) Iñaki Comas et al. NATURE GENETICS
- Interdependence of Cell Growth and Gene Expression: Origins and Consequences
- (2010) M. Scott et al. SCIENCE
- The spectrum of latent tuberculosis: rethinking the biology and intervention strategies
- (2009) Clifton E. Barry et al. NATURE REVIEWS MICROBIOLOGY
- Ultrafast and memory-efficient alignment of short DNA sequences to the human genome
- (2009) Ben Langmead et al. GENOME BIOLOGY
- Biosynthesis and Recycling of Nicotinamide Cofactors inMycobacterium tuberculosis
- (2008) Helena I. M. Boshoff et al. JOURNAL OF BIOLOGICAL CHEMISTRY
Discover Peeref hubs
Discuss science. Find collaborators. Network.
Join a conversationFind the ideal target journal for your manuscript
Explore over 38,000 international journals covering a vast array of academic fields.
Search